ABCB1 and cancer: Previous studies undertaken to identify mechanisms of resistance to romidepsin found that selection with romidepsin in cancer cell line models results in overexpression of the ATP-binding cassette transporter ABCB1 (P-glycoprotein [P-gp])4–7; however, overexpression of ABCB1 was not found in clinical samples obtained from patients with resistant disease.8